ArticleThe Korean journal of internal medicine2021

Effect of omalizumab as add-on therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean patients with severe persistent allergic asthma.

Jae-Woo Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.